PurCell Bio
PrivateLast Round
Accelerator
May 17, 2024
Total Funding Raised
$44,000
Company Overview
PurCell Bio is a biotechnology company that offers a line of cell culture media and media supplements that surpass the growth performance of serum.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PurCell Bio Comps
Public and private peers based on sector, stage, and business model.
PurCell Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 17, 2024 | ||||
| Seed Round | Jan 25, 2024 | ||||
| Grant | Oct 1, 2023 | ||||
| Grant | May 1, 2020 |
Key People
Founding team and executive leadership
PurCell Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Next Frontier Capital | Seed Round |
| Montana Department of Commerce | Grant |
| Jake Jabs College of Business and Entrepreneurship | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2024
$695K raised in Seed Round.
PurCell Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PurCell Bio's valuation, stock price, and market status.